Neoadjuvant Endocrine Therapy Tolerance in Geriatric Early Stage ER+ Breast Cancer
Condition: Breast Cancer Female Interventions: Drug: tamoxifen, letrozole, anastrozole, or exemestane; Behavioral: Patient reported outcomes Sponsor: Trish Millard, MD Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Arimidex | Breast Cancer | Cancer | Cancer & Oncology | Endocrine Therapy | Geriatrics | Neoadjuvant Therapy | Research | Tamoxifen